UBS AM’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,700	Closed	-$55.9K	–	2801
2024 Q1	$55.9K	Hold	19,700	–	–	﹤0.01%	2503
2023 Q4	$290K	Sell	19,700 -8,100	-29%	-$119K	﹤0.01%	2423
2023 Q3	$509K	Buy	+27,800	New	+$509K	﹤0.01%	2290